PCLN, BOFI, ALKS, VRTX, UEIC, PFG, Expected to Trade Lower After Bearish Insider Trading
January 27, 2012 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top insider trading patterns and these stocks are the most likely to trade Lower in the next 6 months. PRICELINE.COM INCORPORATED (NASDAQ:PCLN), BOFI HOLDING, INC. (NASDAQ:BOFI), ALKERMES PLC (NASDAQ:ALKS), VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX), UNIVERSAL ELECTRONICS INC. (NASDAQ:UEIC), PRINCIPAL FINANCIAL GROUP, INCORPORATED (NYSE:PFG) are all expected to go Lower as Sell signals have been generated by top insider trading patterns. The most important data elements considered when performing insider analysis are: Insiders Track Record - An insiders track record is best summarized by the Insider Score which ranges from 1 (least predictive) to 100 (most predictive) based on prior trading performance. In addition, the actual returns following the insiders prior trades are included to determine the potential magnitude of future returns. Insiders Role - Trades by higher-level insiders are generally more predictive than trades by lower level insiders. Higher-level insiders to include Chairman (CB), Chief Executive Officer (CEO), President (P), Chief Financial Officer (CFO), and Vice Chairman (VC).
The chart below displays the stocks expected to go Lower along with the insider name, position, predictive insider score, 6 month expected return and number of trading decisions included in the score.
Symbol Company Name Insider Name Role Shares Insider Score Avg 6 Month Return # of Dec. PCLN PRICELINE.COM INCORPORATED Peretsman, Nancy B D 1,000 81 -50.2% 7 BOFI BOFI HOLDING, INC. Englert, Jerry F D 25,098 87 -10.0% 7 ALKS ALKERMES PLC Pugh, Gordon G O 15,000 90 -5.2% 8 VRTX VERTEX PHARMACEUTICALS INC Kelly-Croswell, Lisa E O 10,166 95 -14.4% 16 UEIC UNIVERSAL ELECTRONICS INC. Arling, Paul D CEO 35,000 78 -6.7% 18 PFG PRINCIPAL FINANCIAL GROUP, INCORPORATED Mccaughan, James Patrick O 6,586 92 -18.8% 5The insider buying report presents recent insider purchases, reported on Forms 3, 4, and 5 filed with the SEC. The transactions are aggregated to a 'decision' level which simplifies the data analysis. A decision is a grouping of buying or selling by an individual at the specified company.
PRICELINE.COM INCORPORATED (NASDAQ:PCLN) - priceline.com Incorporated operates as an online travel company principally in the United States, Europe, and Asia. It provides various travel services, including airline tickets, hotel rooms, car rentals, vacation packages, cruises, and reservation services. The company also provides destination services, such as parking, event tickets, ground transfers, tours, and other services available at their travel destinations; and travel insurance package that provides coverage for trip cancellation, trip interruption, medical expenses, and emergency evacuation, as well as for the loss of baggage, property, and travel documents. In the United States, it offers its customers a choice that gives the ability to purchase travel services in a traditional, price-disclosed manner or the opportunity to use its Name Your Own Price service, which allows the customers to make offers for travel services at discounted prices. The company offers its products and services under priceline.com, Booking.com, Active Hotels, Agoda, Lowestfare.com, Rentalcars.com, Breezenet.com, MyTravelGuide.com, and Travelweb brands. priceline.com Incorporated was founded in 1997 and is headquartered in Norwalk, Connecticut.
BOFI HOLDING, INC. (NASDAQ:BOFI) - BofI Holding, Inc. operates as the holding company for Bank of Internet USA that provides various consumer and wholesale banking services primarily through Internet in the United States. The company accepts various deposit products, including demand deposits, savings accounts, and time deposits. It also offers various loan products comprising single family loans, home equity loans, multifamily loans, commercial real estate loans, consumerrecreational vehicle loans, and overdraft lines of credit. In addition, the company provides online bill payment, online check imaging, ATM card or VISA check card, overdraft protection, and electronic statement services. It serves approximately 32,000 retail deposit and loan customers across 50 states. The company was incorporated in 1999 and is headquartered in San Diego, California.
ALKERMES PLC (NASDAQ:ALKS) - Alkermes, Inc., an integrated biotechnology company, provides extended-release injectable and oral products for the treatment of prevalent and chronic diseases, such as central nervous system disorders, reward disorders, addiction, diabetes, and autoimmune disorders. The company develops, manufactures, and commercializes VIVITROL, an injectable medication for the treatment of alcohol dependence; and manufactures RISPERDAL CONSTA for the treatment of schizophrenia and bipolar I disorders. It is also developing BYDUREON, a once weekly formulation of exenatide for the treatment of type 2 diabetes; ALKS 33, an oral opioid modulator for the potential treatment of addiction and other CNS disorders; ALKS 37, an orally active, peripherally-restricted opioid antagonist for the treatment of opioid-induced constipation; ALKS 9070, a once-monthly, injectable, sustained-release version of aripiprazole for the treatment of schizophrenia; ALKS 6931, a long-acting form of a TNF receptor-FC fusion protein for the treatment of rheumatoid arthritis and related autoimmune diseases; and ALKS 7921, a once-monthly, injectable, and extended-release version of olanzapine for the treatment of schizophrenia. The company has collaborative arrangements with Janssen Pharmaceutica, Inc.; Amylin Pharmaceuticals, Inc.; Cilag GmbH International; Rensselaer Polytechnic Institute; and Acceleron Pharma, Inc. Alkermes, Inc. was founded in 1987 and is headquartered in Waltham, Massachusetts.
VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) - Vertex Pharmaceuticals Incorporated engages in the discovery, development, and commercialization of small molecule drugs for the treatment of serious diseases worldwide. Its product pipeline includes Telaprevir (VX-950), a Phase III clinical trial product for the treatment of hepatitis C virus (HCV) infection; VX-222, a Phase IIa clinical trial product targeting HCV infection; VX-770, a Phase III clinical trial candidate for the treatment of cystic fibrosis; and VX-809, a Phase IIa clinical trial product targeting cystic fibrosis. The companys products also comprise VX-509, a Phase IIa clinical trial product for the treatment of rheumatoid arthritis; VX-765, a Phase IIa clinical trial product targeting epilepsy; and VX-759, a Phase I clinical trial product for the treatment of HCV infection. It has collaboration agreements with Janssen Pharmaceutica, N.V.; Mitsubishi Tanabe Pharma Corporation; Cystic Fibrosis Foundation Therapeutics Incorporated; Merck & Co., Inc.; and GlaxoSmithKline plc. The company was founded in 1989 and is headquartered in Cambridge, Massachusetts.
UNIVERSAL ELECTRONICS INC. (NASDAQ:UEIC) - Universal Electronics Inc. and its subsidiaries develop pre-programmed wireless control products and audio-video accessories that enhance home entertainment systems. The company offers infrared and radio frequency remote controls; audio-video accessories; integrated circuits; and software, firmware, and technology solutions that enable devices, such as televisions, set-top boxes, stereos, automotive audio systems, cell phones, and other consumer electronic devices to wirelessly connect and interact with home networks and interactive services to deliver digital entertainment and information. It also licenses its intellectual property primarily to original equipment manufacturers (OEMs), software development companies, private labels, and multiple systems operators. Universal Electronics Inc. sells its products directly, as well as through retailers and distributors in Europe, Australia, New Zealand, South Africa, the Middle East, Mexico, Asia, and Latin America under the One For All name. Its primary markets include cable and satellite service providers, retail, OEMs, custom installers, private label, and companies in the personal computing industry. The company was founded in 1986 and is headquartered in Cypress, California.
PRINCIPAL FINANCIAL GROUP, INCORPORATED (NYSE:PFG) - Principal Financial Group, Inc. provides retirement savings, investment, and insurance products and services worldwide. It operates in four segments: U.S. Asset Accumulation, Global Asset Management, International Asset Management and Accumulation, and Life and Health Insurance. The U.S. Asset Accumulation segment offers defined contribution pension plans, including 401(k) and 403(b) plans, defined benefit pension plans, nonqualified executive benefit plans, and employee stock ownership plan consulting services to small and medium-sized businesses; investment-only products, such as guaranteed investment contracts and funding agreements to large institutional clients; and the ability to accumulate funds for retirement and savings through mutual funds, individual annuities, and bank products to employees of businesses and other individuals. The Global Asset Management segment provides asset management services covering a range of asset classes, investment styles, and portfolio structures to its other segments and third-party institutional clients. This segment principally offers investment advisory services across three asset classes comprising equity investments, fixed income investments, and real estate investments. The International Asset Management and Accumulation segment offers long-term savings, retirement annuities, asset accumulation, mutual funds, life insurance, mortgage loans, and institutional asset management products and services. The Life and Health Insurance segment provides individual life insurance and group health insurance products and services, as well as other specialty benefits consisting of group dental and vision, group life, group long-term and short-term disability, and individual disability insurance services. The company was founded in 1879 and is based in Des Moines, Iowa.
About BUYINS.NET
BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:
REGULATORY & COMPLIANCE NEWS
Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"
RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO
INVESTMENTS & TRADING
SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.
Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.
Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.
Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.
Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.
GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.
Insider Trading tracks all insider trades and selects those insider buys that predict higher moves and insider sales that predict lower moves.
DISCLAIMER:
BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.
Contact:
BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net